Abstract
We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a antibody.
| Original language | English |
|---|---|
| Pages (from-to) | 117-9 |
| Number of pages | 3 |
| Journal | Orbit (Amsterdam, Netherlands) |
| Volume | 24 |
| DOIs | |
| Publication status | Published - 1 Jun 2005 |